Eli Lilly (LLY) Inventory Average (2016 - 2025)
Eli Lilly's Inventory Average history spans 17 years, with the latest figure at $13.0 billion for Q4 2025.
- For Q4 2025, Inventory Average rose 72.27% year-over-year to $13.0 billion; the TTM value through Dec 2025 reached $13.0 billion, up 72.27%, while the annual FY2025 figure was $10.7 billion, 59.66% up from the prior year.
- Inventory Average reached $13.0 billion in Q4 2025 per LLY's latest filing, up from $11.6 billion in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $13.0 billion in Q4 2025 to a low of $3.7 billion in Q2 2021.
- Average Inventory Average over 5 years is $6.0 billion, with a median of $4.8 billion recorded in 2023.
- Peak YoY movement for Inventory Average: fell 0.02% in 2022, then skyrocketed 72.27% in 2025.
- A 5-year view of Inventory Average shows it stood at $3.9 billion in 2021, then rose by 4.46% to $4.1 billion in 2022, then skyrocketed by 31.12% to $5.3 billion in 2023, then skyrocketed by 40.98% to $7.5 billion in 2024, then soared by 72.27% to $13.0 billion in 2025.
- Per Business Quant, the three most recent readings for LLY's Inventory Average are $13.0 billion (Q4 2025), $11.6 billion (Q3 2025), and $10.2 billion (Q2 2025).